Back

Select your region

Arrange a consultation about stem cells

Learn more

List of life saving
transplantations

List of uses for stem cells approved by the FamiCord Group’s laboratories:

Image
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
5301 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 26
5302 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 52
5303 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 38
5304 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2019 Standard Therapy Germany 56
5305 Apheresis Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2019 Standard Therapy Germany 51
5306 Apheresis Autologous Amyloidosis Hematology 2019 Standard Therapy Germany 60
5307 Apheresis Allogeneic Aplasia Hematology 2019 Standard Therapy Poland 51
5308 Apheresis Allogeneic Aplastic Anemia Hematology 2019 Standard Therapy Poland 16
5309 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Poland 8
5310 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 46
5311 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 21
5312 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2019 Standard Therapy Germany 28
5313 Apheresis Allogeneic B-Cell Chronic Lymphoblastic Leukemia Hematology 2019 Standard Therapy Poland 66
5314 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma Hematology 2019 Standard Therapy Germany 66
5315 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 2
5316 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 16
5317 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2019 Standard Therapy Poland 3
5318 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 58
5319 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 65
5320 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 69
5321 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 65
5322 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 60
5323 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2019 Standard Therapy Poland 69
5324 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 23
5325 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 34
5326 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 37
5327 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 56
5328 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 58
5329 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 56
5330 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 31
5331 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 54
5332 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2019 Standard Therapy Poland 46
5333 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 54
5334 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 65
5335 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 73
5336 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2019 Standard Therapy Poland 62
5337 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2019 Standard Therapy Germany 66
5338 Apheresis Autologous Embryonal Cell Carcinoma Of The Testicle Hematology 2019 Standard Therapy Germany 29
5339 Apheresis Allogeneic Extracranial Malignant Germ Cell Tumors Hematology 2019 Standard Therapy Poland 53
5340 Apheresis Allogeneic Glanzmann Thrombasthenia Hematology 2019 Standard Therapy Poland 11
5341 Apheresis Allogeneic High-Risk Myelodysplastic Syndrome Hematology 2019 Standard Therapy Poland 61
5342 Apheresis Allogeneic Histiocytosis X Hematology 2019 Standard Therapy Poland 14
5343 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 65
5344 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 58
5345 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 28
5346 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 44
5347 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 1
5348 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 32
5349 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2019 Standard Therapy Poland 34
5350 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 62
5351 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 69
5352 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2019 Standard Therapy Poland 65
5353 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 66
5354 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 63
5355 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
5356 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 68
5357 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 65
5358 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 54
5359 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 64
5360 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
5361 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 59
5362 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 71
5363 Apheresis Autologous Mantle Cell Lymphoma Hematology 2019 Standard Therapy Germany 63
5364 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2019 Standard Therapy Poland 59
5365 Apheresis Allogeneic Mixed Phenotype Acute Leukemia Hematology 2019 Standard Therapy Poland 49
5366 Apheresis Autologous Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy Hematology 2019 Standard Therapy Germany 36
5367 Apheresis Autologous Morbus Hodgkin Hematology 2019 Standard Therapy Germany 66
5368 Apheresis Allogeneic Mucopolysaccharidosis Type I Metabolic 2019 Standard Therapy Poland 1
5369 Apheresis Allogeneic Mucopolysaccharidosis Type Ii Metabolic 2019 Standard Therapy Poland 2
5370 Apheresis Allogeneic Mucopolysaccharidosis Type Ii Metabolic 2019 Standard Therapy Poland 2
5371 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Poland 52
5372 Apheresis Allogeneic Multiple Myeloma Hematology 2019 Standard Therapy Poland 55
5373 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
5374 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
5375 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
5376 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 69
5377 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 58
5378 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 65
5379 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
5380 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 56
5381 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 54
5382 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 51
5383 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
5384 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
5385 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 61
5386 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
5387 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
5388 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
5389 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 39
5390 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 52
5391 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 59
5392 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63
5393 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 40
5394 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 57
5395 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 53
5396 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 64
5397 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 70
5398 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 68
5399 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 56
5400 Apheresis Autologous Multiple Myeloma Hematology 2019 Standard Therapy Germany 63